Novartis | NOVN - Eps Gewinn Pro Aktie

Aktienkurs
114.72
Täglich Wechseln
0.64 0.56%
Monatlich
-4.26%
Jährlich
21.77%
Q2 Prognose
111.47

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.99 2.28 Apr/28
FY2025Q4 Dec/2025 2.03 1.98 Apr/02
FY2025Q3 Sep/2025 2.04 1.58 Oct/28
FY2025Q2 Jun/2025 2.42 1.97 Jul/17
FY2025Q1 Mar/2025 2.28 1.80 Apr/29




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Alcon AG USD 0.78 0.01 2025-12
Almirall EUR 0.07 0.03 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Autolus Therapeutics Ltd USD -0.34 0.04 2025-12
Bayer EUR 0.62 0.05 2025-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Fresenius EUR 0.78 0.04 2025-12
Fresenius Medical Care EUR 1.44 0.34 2025-12
Galapagos EUR 11.89 12.3 2025-12
Genmab DKK 3.69 2.77 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
GRIFOLS EUR 0.25 0.04 2025-12
Hikma Pharmaceutical USD 0.65 0.12 2025-12
J&J USD 2.7 0.24 2026-03
Lonza CHF 6.07 1.92 2025-06
Merck EUR 1.88 0.44 2025-12
Merck USD 2.04 0.54 2025-12
Novartis USD 1.99 0.04 2026-03
Novartis USD 1.99 0.45 2026-03
Novo Nordisk DKK 6.04 1.54 2025-12
Orion EUR 0.66 1.19 2026-03
Pfizer USD 0.66 0.21 2025-12
Philips EUR 0.6 0.24 2025-12
Recordati EUR 0.73 0.06 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.88 0.35 2026-03
UCB EUR 5.65 3.21 2025-12